Cue Overall health steps outside the house diagnostics to provide digital overall health platform

Cue Wellness, finest recognised for its at-home COVID-19 molecular examination, will start its very own virtual well being platform, pushing the business outside of the diagnostics place.

The immediate-to-customer platform, accessible on Nov. 15, will include things like on-desire obtain to medical practitioners, guided COVID-19 screening, prescriptions and medical professional-purchased lab assessments. The virtual care choices are part of a membership software, exactly where shoppers can pay back a every month price for a selection of checks for each yr, as well as savings on a Cue Reader and more assessments.

“I think the differentiator listed here is that we lead with an particularly potent, capable diagnostic merchandise and the capability to hook up that check outcome to a health practitioner instantly if you would like to,” Clint Sever, Cue Health’s co-founder and chief merchandise officer, informed MobiHealthNews.

“Or you can appear to the system for any purpose and obtain our suite of health professionals. They can prescribe for any issue that they need to have to, so there is a lot of overall flexibility developed into the platform that we feel is truly essential.”

WHY IT Issues

As soon as a extra specialized niche method of health care shipping and delivery, telehealth and digital-care use exploded during the pandemic as sufferers and providers prevented needless in-person treatment. However telehealth utilization experienced been declining in June and July, Reasonable Health’s Month-to-month Telehealth Regional Tracker located utilization grew nationally in August, particularly in the South as the delta variant distribute in the location.

And as much more people return to travel, team gatherings and functions, Sever claimed the supervised COVID-19 screening capabilities made available as aspect of Cue’s virtual care will also aid differentiate its system.

“A large amount of folks, especially when they journey, want that lab-excellent final result,” Sever reported. “But they are not able to get that lab-good quality final result except they go by way of a truly arduous method of showing up at a testing website and waiting 24 hours to 48 several hours for check final results, which may perhaps or may well not get shipped to them on time, particularly if you’re on a tight timeline.”

THE Larger sized Pattern

Cue has experienced a chaotic 2021. In March, it been given unexpected emergency use authorization from the Food items and Drug Administration for its diagnostic COVID-19 examination that doesn’t need a prescription and can be utilised at house. It had first been given an EUA for a issue-of-treatment test in June 2020.

The company scored a hefty $235 million in new funding in Might, and declared programs to go public in early September. By the finish of the thirty day period, it had kicked off its $200 million initial public providing.

Sever explained the corporation is functioning on growing diagnostic choices that will be suitable with the Cue Reader, including tests for flu, RSV (respiratory syncytial virus), chlamydia, gonorrhea, fertility and pregnancy. But Cue’s very long-term plans go outside of diagnostics.

“The purpose is constantly enabling any person to accessibility the health care procedure, from house or where ever they are. To make that incredibly effortless, to provide the health care system to you,” Sever reported. “So that digital transformation of the healthcare process stays our mission. And I assume this DTC [direct-to-consumer] start is the first key stage in enabling that larger sized eyesight.”